APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 93 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,439,944 | -79.4% | 169,294 | -50.5% | 0.01% | -78.7% |
| Q2 2023 | $31,188,267 | +411.5% | 342,352 | +270.3% | 0.06% | +369.2% |
| Q1 2023 | $6,097,738 | -73.0% | 92,446 | -78.8% | 0.01% | -74.5% |
| Q4 2022 | $22,567,433 | -1.9% | 436,423 | +29.6% | 0.05% | +2.0% |
| Q3 2022 | $22,998,000 | -62.8% | 336,727 | -75.4% | 0.05% | -60.6% |
| Q2 2022 | $61,880,000 | +33.1% | 1,368,407 | +49.5% | 0.13% | +44.3% |
| Q1 2022 | $46,499,000 | +6988.3% | 915,163 | +8720.8% | 0.09% | +2833.3% |
| Q2 2021 | $656,000 | +1357.8% | 10,375 | +206.8% | 0.00% | – |
| Q4 2018 | $45,000 | – | 3,382 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |